Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Frontiers in Psychiatry
|
July 3, 2024
Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System
Tigran Makunts, Ruben Abagyan
Scientific Reports
|
December 15, 2021
Common osteoporosis drug associated with increased rates of depression and anxiety
Dro Keshishi, Tigran Makunts, Ruben Abagyan
Jmirx Med
|
May 13, 2024
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis
Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System
Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan
Scientific Reports
|
June 27, 2023
Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
Haroutyun Joulfayan, Tigran Makunts, Ruben Abagyan
Scientific Reports
|
August 1, 2020
Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
Tigran Makunts, Marc Axel Wollmer, Ruben Abagyan
Plos One
|
February 10, 2022
Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events
Tigran Makunts, Keith Burkhart, Ruben Abagyan, et al.
Cancers
|
August 29, 2024
Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events
Siranuysh Grabska, Hovakim Grabski, Tigran Makunts, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 26, 2024
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events
Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, et al.
Scientific Reports
|
August 30, 2019
Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
Tigran Makunts, Andrew U, Rabia S Atayee, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Frontiers in Psychiatry
|
July 3, 2024
Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System
Tigran Makunts, Ruben Abagyan
Scientific Reports
|
December 15, 2021
Common osteoporosis drug associated with increased rates of depression and anxiety
Dro Keshishi, Tigran Makunts, Ruben Abagyan
Jmirx Med
|
May 13, 2024
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis
Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System
Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan
Scientific Reports
|
June 27, 2023
Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
Haroutyun Joulfayan, Tigran Makunts, Ruben Abagyan
Scientific Reports
|
August 1, 2020
Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
Tigran Makunts, Marc Axel Wollmer, Ruben Abagyan
Plos One
|
February 10, 2022
Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events
Tigran Makunts, Keith Burkhart, Ruben Abagyan, et al.
Cancers
|
August 29, 2024
Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events
Siranuysh Grabska, Hovakim Grabski, Tigran Makunts, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 26, 2024
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events
Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, et al.
Scientific Reports
|
August 30, 2019
Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
Tigran Makunts, Andrew U, Rabia S Atayee, et al.
Page
of 3